I.L. Paiva et al. / Polyhedron 62 (2013) 104–109
105
activities. Recently, silver(I) complexes with alfa-hydroxy-acids
[6], aminoacids [7], benzotiazoles [8] and mercaptopurine [9], syn-
thesized in our laboratories, have been shown to be more effective
than SSD against M. tuberculosis. The mechanisms of antibacterial
action of the Ag(I) complexes have been poorly described. How-
ever, there are three possibilities: (i) interference with electron
transport; (ii) inhibition of bacterial deoxyribonucleic acid (DNA)
replication caused by the Ag(I) ion, and (iii) modification of the
bacterial cell membrane [6].
with distilled water and ether, and stored in a desiccator under sil-
ica. When ethylenediamine was used, a white crystalline solid was
obtained (15.6 g, 52.7 mmol, 95.4% yield, MBDA). A pale yellow so-
lid was obtained using 1,3-diaminopropane as reagent (16.5 g,
53.2 mmol, 96.2% yield, MBDB).
Elemental Anal. Calc. for MBDA (C18H20N2O2): C, 72.9; H, 6.80;
N, 9.45. Found: C, 73.2; H, 6.93; N, 9.90%. Elemental Anal. Calc.
for MBDB (C19H22N2O2): C, 73.5; H, 7.14; N, 9.03. Found: C, 73.2;
H, 6.90; N, 9.15%.
Schiff bases are typically obtained by condensation of amine
compounds and active carboxyl groups (aldehyde and ketone)
leading to –CH@N– groups [10]. Schiff base compounds have re-
ceived special attention due to their simple methods of preparation
and to their versatility of applications, especially in biological field
[11].
Here, we describe the synthesis, structural characterization, DFT
studies and biological assays of two Schiff bases named MBDA and
MBDB (see Fig. 1) and their silver(I) complexes, named AgMBDA
and AgMBDB, respectively. The crystal structure of AgMDBA is also
reported.
2.3. Synthesis of the Ag(I) complexes with MBDA and MBDB
2.3.1. AgMBDA complex
An ethanolic solution containing 0.592 g (2.0 mmol, 30 mL) of
MBDA was first prepared. Then, a silver nitrate solution (0.170 g,
1.0 mmol), prepared in a minimum of water (ꢁ1 mL) and diluted
with 10.0 mL of ethanol was added under vigorous stirring to the
MBDA solution. Immediately, a yellow solid was formed. The solu-
tion was filtered and the solid was washed three times with 5 mL
of cold ethanol. The solid was collected and dried in a desiccator
over P4O10. The filtrate was left to stand overnight and light-yellow
crystals suitable for X-rays studies were obtained. Yield ꢁ80%
(crystals plus powder). Elemental Anal. Calc. for [Ag(C18H20N2O2)2]-
NO3: C, 56.7; H, 5.29; N, 9.18; O, 14.7; Ag, 14.1. Found: C, 56.7; H,
5.38; N, 9.95; Ag, 14.3% (from the TG curve).
2. Experimental
2.1. Materials and measurements
The starting compounds p-anisaldehyde (98%), ethylenedia-
mine (>99.5%) and 1,3-diaminopropane (>99%) were purchased
from Sigma–Aldrich Laboratory Co., and silver nitrate (>99%) was
purchased from Acros Organics. All chemical reagents were used
without further purification. Elemental analyses of C, H and N were
performed on a CHNS-O EA 1110 Analyzer, CE Instruments. Ther-
mal analyses were performed on a DTG-60 Simultaneous DTA-TG
apparatus, Shimadzu, using the following conditions: synthetic
air, flow rate of 50 cm3 minꢀ1 and heating rate of 10 °C minꢀ1, from
25 to 700 °C for both complexes. The IR spectra were recorded on a
Spectrum 2000 FT-IR Perkin Elmer spectrophotometer in the range
2.3.2. AgMBDB complex
The synthesis of AgMBDB complex was performed by the reac-
tion of 0.310 g (1.0 mmol) of MBDB in 20 mL of THF, with a silver
nitrate solution previously prepared by adding 0.0849 g of AgNO3
to a mixture of water (less than 1.0 mL) and THF (10.0 mL). The sil-
ver nitrate solution was added to MBDB slowly and under stirring.
A white crystalline powder was obtained. The final solution was
left to stand for several days and elongated crystals were obtained.
However, the crystals were not suitable for single X-ray crystallo-
graphic studies. X-ray analysis using the powder diffraction meth-
odology are in progress. Yield ꢁ80%. Elemental Anal. Calc. for
[Ag(C19H22N2O2)NO3]ꢂ½H2O: C, 46.6; H, 4.74; N, 8.59; O, 18.0; Ag,
22.0. Found C, 46.5; H, 4.17; N, 8.69; Ag, 21.7% (from the TG curve).
4000–300 cmꢀ1. The samples were prepared as KBr pellets. The 13
C
and 1H NMR data for MBDA and AgMBDA were recorded on a Bru-
ker 500 MHz and for MBDB and AgMBDB samples were recorded
on a Bruker 250 MHz. Tetramethylsilane was used as the internal
standard. All NMR samples were prepared in deuterated dimethyl-
sulfoxide solutions – (CD3)2SO.
2.4. Structural characterization of the AgMBDA complex
Single-crystal data were collected using an Oxford GEMINI A-
Ultra CCD diffractometer with Mo K
a (k = 0.71073 Å) radiation at
2.2. Synthesis of Schiff bases
room temperature. The data collection, cell refinement and data
reduction were performed using the CRYSALISPRO software [12]. The
structure was solved by direct methods using SHELXS and refined
using SHELXL [13]. An empirical isotropic extinction parameter x
was refined according to the method described by Larson [14].
The C-bound H-atoms were included in calculated positions and
treated as riding atoms using SHELXL default parameters. The non-
H atoms were refined anisotropically, using weighted full-matrix
least-squares on F2. A semi-empirical absorption correction (mul-
ti-scan) was applied using CRYSALISPRO [12]. The structures were
drawn using ORTEP-3 for WINDOWS [15] and MERCURY [16].
To a 100 mL round bottom flask was added 55.3 mmol of ethy-
lenediamine (3.20 mL) or 1,3-diaminopropane (4.10 mL) in 50 mL
of absolute ethanol. Then, with continuous stirring, 15.1 mL
(110.8 mol) of p-anisaldehyde was slowly added. The reaction
was carried out under constant stirring at room temperature dur-
ing 4 h. The precipitates were then collected by filtration, washed
2.5. Antibacterial assays
The anti M. tuberculosis (anti-MTB) activities of the compounds
were determined by the Resazurin Microtiter Assay (REMA) [17].
Stock solutions of the test compounds were prepared in dimethyl
sulfoxide (DMSO) and diluted in Middlebrook 7H9 broth (Difco),
supplemented with oleic acid, albumin, dextrose and catalase
(OADC enrichment – BBL/Becton Dickinson, Sparks, MD, USA), to
obtain final drug concentration ranges from 0.15 to 250
lg/mL.
Fig. 1. Schematic structures for MBDA and MBDB.
The serial dilutions were realized in a Precision XS Microplate Sam-